The in vitro Effects of Various Immunomodulatory Nutritional Compounds on Antigen-Stimulated Whole-Blood Culture Cytokine Production

Immunomodulators are substances that alter immune
system via dynamic regulation of messenger molecules. It can be
divided into immunostimulant and immunosuppressant. It can help to
increase immunity of people with a low immune system, and also can
help to normalize an overactive immune system. Aim of this study is
to investigate the effects of in vitro exposure to low and high doses of
several immunomodulators which include caffeine, kaloba and
quercetin on antigen-stimulated whole blood culture cytokine
production. Whole blood samples were taken from 5 healthy males
(age: 32 ± 12 years; weight: 75.7 ± 6.1 kg; BMI: 24.3 ± 1.5 kg/m2)
following an overnight fast with no vigorous activity during the
preceding 24 h. The whole blood was then stimulated with 50 μl of
100 x diluted Pediacel vaccine and low or high dose of
immunomodulators in the culture plate. After 20 h incubation (5%
CO2, 37°C), it was analysed using the Evidence Investigator to
determine the production of cytokines including IL-2, IL-4, IL-10,
IFN-γ, and IL-1α. Caffeine and quercetin showed a tendency towards
decrease cytokine production as the doses were increased. On the
other hand, an upward trend was evident with kaloba, where a high
dose of kaloba seemed to increase the cytokine production. In
conclusion, we found that caffeine and quercetin have potential as
immunosuppressant and kaloba as immunostimulant.

• Ayu S. Muhamad
• Michael Gleeson

• Caffeine
• cytokine
• immunomodulators
• kaloba
• quercetin.

[1] Patil, U. S., Jaydeokar, A. V., and Bandawane, D. D. (2012).
Immunomodulators: A pharmacological review. Int J Pharm PharmSci,
4(1), 30-36.
[2] Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S. and
Tenborg, M. (2006). Modulation of cytokine expression by traditional
medicines: a review of herbal immunomodulators. Altern Med Rev,
11(2), 128-150.
[3] Del-Rio-Navarro, B. E., Espinosa Rosales, F., Flenady, V. and Sienra-
Monge, J. J. (2006). Immunostimulants for preventing respiratory tract
infection in children. Cochrane Database Syst Rev, 18(4), CD004974.
[4] Horrigan, L. A., Kelly, J. P. and Connor, T. J. (2004). Caffeine
suppresses TNF-alpha production via activation of the cyclic
AMP/protein kinase A pathway. IntImmunopharmacol, 4(10-11), 1409-
1417.
[5] Horrigan, L. A., Kelly, J. P. and Connor, T. J. (2006).
Immunomodulatory effects of caffeine: friend or foe? PharmacolTher,
111(3), 877-892.
[6] Chen, C. C., Kong, M. S., Lai, M. W., Chao, H. C., Chang, K. W., Chen,
S. Y., Huang, Y. C., Chiu, C. H., Li, W. C., Lin, P. Y., Chen, C. J. and
Li, T. Y. (2010). Probiotics have clinical, microbiological, and
immunologic efficacy in acute infectious diarrhea. Pediatr Infect Dis J,
29(2), 135-138.
[7] Chuang, C. C., Martinez, K., Xie, G., Kennedy, A., Bumrungpert, A.,
Overman, A., Jia, W. and McIntosh, M. K. (2010). Quercetin is equally
or more effective than resveratrol in attenuating tumor necrosis factor-
{alpha}-mediated inflammation and insulin resistance in primary human
adipocytes. Am J ClinNutr, 92(6), 1511-1521.
[8] Kolodziej, H. and Kiderlen, A. F. (2007). In vitro evaluation of
antibacterial and immunomodulatory activities of Pelargonium
reniforme, Pelargonium sidoides and the related herbal drug preparation
EPs 7630. Phytomedicine. 14(Suppl 6), 18-26.
[9] Trun, W. et al., (2006). Nitric oxide synthase and cytokine gene
expression analyses in Leishmania-infected RAW 264.7 cells treated
with an extract of Pelargonium sidoides (EPs7630). Phytomedicine, 13,
570-575.
[10] Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A. and Zvartau, E. E.
(1999). Actions of caffeine in the brain with special reference to factors
that contribute to its widespread use. Pharmacol Rev, 51(1), 83-133.
[11] Kolodziej, H. (2000). Traditionally used Pelargonium species: chemistry
and biological activity of umckaloabo extracts and their constituents.
Curr Top Phytochem, 3, 77-93.
[12] Lewu, F. B., Grierson, D. S. and Afolayan, A. J. (2006). Clonal
propagation of Pelargonium sidoides: a threatened medicinal plant of
South Africa. Afr J Biotechnol, 5, 123-125.
[13] Matthys, H. and Funk, P. (2008). EPs7630 improves acute bronchitis
symptoms and shortens time to remission. Results of a randomised,
double-blind, placebo-controlled, multicentre trial. Planta Med, 74(6),
686-692.
[14] Thäle, C., Kiderlen, A. and Kolodziej, H. (2008). Anti-infective mode of
action of EPs 7630 at the molecular level. Planta Med, 74(6), 675-681.
[15] Matthys, H., Lizogub, V. G., Malek, F. A. and Kieser, M. (2010).
Efficacy and tolerability of EPs 7630 tablets in patients with acute
bronchitis: a randomised, double-blind, placebo-controlled dose-finding
study with a herbal drug preparation from Pelargonium sidoides. Curr
Med Res Opin, 26(6), 1413-1422.
[16] Davis, J. M., Murphy, E. A. and Carmichael, M. D. (2009). Effects of
the dietary flavonoid Quercetin upon performance and health. Curr
Sports Med Rep, 8(4), 206-213.
[17] Nieman, D. C., Henson, D. A., Gross, S. J., Jenkins, D. P., Davis, J. M.,
Murphy, E. A., Carmichael, M. D., Dumke, C. L., Utter, A. C.,
McAnulty, S. R., McAnulty, L. S., and Mayer, E. P. (2007b). Quercetin
reduces illness but not immune perturbations after intensive exercise.
Med Sci Sports Exerc, 39(9), 1561-1569.
[18] Fletcher, D. K. and Bishop, N. C. (2011). Effect of a high and low dose
of caffeine on antigen-stimulated activation of human natural killer cells
after prolonged cycling. Int J Sport NutrExercMetab, 21(2), 155-165.
[19] Nieman, D. C., Henson, D. A., Davis, J. M., Dumke, C. L., Gross, S. J.,
Jenkins, D. P., Murphy, E. A., Carmichael, M. D., Quindry, J. C.,
McAnulty, S. R. and McAnulty, L. S., Utter, A. C. and Mayer, E. P.
(2007a). Quercetin ingestion does not alter cytokine changes in athletes
competing in the Western States Endurance Run. J Interferon Cytokine
Res, 27(12), 1003-1011.
[20] Conrad, A. et al., (2007). Extract of Pelargonium sidoides (EPs7630)
improves phagocytosis, oxidative bursts, and intracellular killing of
human peripheral blood phagocytes in-vitro. Phytomedicine, 14(Suppl.
VI), 46-51.
[21] Mandel, H. G. (2002). Update on caffeine consumption, disposition and
action. Food ChemToxicol, 40(9), 1231-1234.
[22] Haskó, G., Kuhel, D. G., Chen, J. F., Schwarzschild, M. A., Deitch, E.
A., Mabley, J. G., Marton, A. and Szabó, C. (2000). Adenosine inhibits
IL-12 and TNF-[alpha] production via adenosine A2a receptordependent
and independent mechanisms. FASEB J, 14(13), 2065-2074.
[23] Link, A. A., Kino, T., Worth, J. A., McGuire, J. L., Crane, M. L.,
Chrousos, G. P., Wilder, R. L. and Elenkov, I. J. (2000). Ligandactivation
of the adenosine A2a receptors inhibits IL-12 production by
human monocytes. J Immunol, 164(1), 436-442.
[24] Goossens, V., Stangé, G., Moens, K., Pipeleers, D. and Grooten, J.
(1999). Regulation of tumor necrosis factor-induced, mitochondria- and
reactive oxygen species-dependent cell death by the electron flux
through the electron transport chain complex I. Antioxid Redox Signal,
1(3), 285-295.
[25] Kayser, O. et al., (2007). Immunomodulatory principles of Pelargonium
sidoides. Phyter Res, 15, 122-126.
[26] Neugebauer, P. et al. (2005). A new approach to pharmacological effects
on ciliary beat frequency in cell cultures – exemplary measurements
under Pelargonium sidoides extract. Phytomedicine, 12, 47-52.